High Efficacy of Dupilumab in Omalizumab-Refractory Severe Chronic Spontaneous Urticaria and Delayed Pressure Urticaria

被引：0
|
作者：
Pastor-Nieto, M. A. [1 ,2 ,3 ,4 ,5 ]
Gatica-Ortega, M. E. [4 ]
机构：
[1] Hosp Univ Fdn Jimenez Diaz, Serv Dermatol, Madrid, Spain
[2] Hosp Univ Guadalajara, Serv Dermatol, Guadalajara, Madrid, Spain
[3] Univ Alcala, Fac Med & Ciencias Salud, Dept Med & Especial Med, Alcala De Henares, Spain
[4] Univ Castilla La Mancha, Albacete, Spain
[5] Complejo Hospitalario Univ Toledo, Serv Dermatol, Toledo, Spain
来源：
ACTAS DERMO-SIFILIOGRAFICAS | 2025年 / 116卷 / 02期
关键词：
D O I：
10.1016/j.ad.2023.07.038
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：191 / 193
页数：3
相关论文
共 50 条
  • [21] Treatment response to omalizumab in patients with refractory chronic spontaneous urticaria
    Syrigos, Nikolaos
    Grapsa, Dimitra
    Zande, Maria
    Tziotou, Marianna
    Syrigou, Ekaterini
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (04) : 417 - 422
  • [22] What are the effects of omalizumab in patients with refractory chronic spontaneous urticaria?
    Lopez, Mario
    Navajas-Galimany, Lucas
    MEDWAVE, 2015, 15 : e6346
  • [23] Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria
    Yang, Liu
    Yu, Rentao
    Qian, Weilu
    Zheng, Qiu
    Xiong, Jianxia
    Chen, Shuang
    Chen, Aijun
    Chen, Jin
    Fang, Sheng
    Huang, Kun
    Cai, Tao
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (07) : 643 - 655
  • [24] Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria
    Nettis, Eustachio
    Cegolon, Luca
    Macchia, Luigi
    Zaza, Ippolita
    Calogiuri, Gianfranco
    Di Leo, Elisabetta
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 (04) : 446 - 448
  • [25] Efficacy of bilastine updosing in refractory moderate to severe chronic spontaneous urticaria
    Weller, K.
    Andre, F.
    Schoepke, N.
    Ohanyan, T.
    Zuberbier, T.
    Maurer, M.
    ALLERGY, 2016, 71 : 298 - 299
  • [26] Xolair (omalizumab) in Treatment of Severe Refractory Chronic Idiopathic Urticaria
    Sussman, G.
    Leader, N.
    Merman, E.
    Melvin, R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB101 - AB101
  • [27] Omalizumab (Xolair) in the Treatment of Severe Refractory Chronic Urticaria (SRCIU)
    Giruparajah, M.
    Berlin, N.
    Maclachlan, S.
    Sussman, G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB225 - AB225
  • [28] DELAYED PRESSURE URTICARIA TREATED WITH OMALIZUMAB
    Hartog, N. L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A82 - A83
  • [29] Efficacy of omalizumab in the treatment of 12 patients with severe chronic idiopathic urticaria refractory to immunosuppressants
    Ganesha, A.
    Huntington, S.
    Toolan, J.
    Ford, K.
    Wood, P. M.
    Savic, S.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2013, 43 (12): : 1449 - 1449
  • [30] Value of omalizumab in chronic refractory urticaria
    Armengot-Carbo, Miquel
    Rodrigo-Nicolas, Beatriz
    Gimeno Carpio, Enrique
    Velasco Pastor, Manuel
    Pont Sanjuan, Virginia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB5 - AB5
12345